跳至主要内容
临床试验/ISRCTN35898459
ISRCTN35898459已完成4 期

Randomised controlled trial of treatments for pyoderma gangrensoum

ottingham University Hospitals NHS Trust (UK)0 个研究点目标入组 140 人开始时间: 2009年5月26日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. PG as diagnosed by the recruiting dermatologist. An ulcerative lesion may have mixed aetiology, but provided the investigator has confidence that a clinical diagnosis of PG is appropriate then they are eligible. Other contributing factors and atypical features will be captured in the case report form.
  • 2. Must have a measurable ulceration (e.g., not pustular pyoderma gangrenosum)
  • 3. Age over 18 years, either sex
  • 4. Able to provide written, informed consent

排除标准

  • Patients cannot participate in either arms of the trial if they have any of the following:
  • 1. Granulomatous PG - this condition is very rare and may respond differently to treatment
  • 2. Concomitant ciclosporin, prednisolone or intravenous immunoglobulin (IVIG) therapy in the previous month
  • 3. Already participating in another clinical trial
  • Exclusions for the randomised controlled trial only are as follows:
  • 4. Pregnant, lactating or at risk of pregnancy
  • 5. Hypersensitivity to prednisolone or ciclosporin
  • 6. Biopsy not consistent with PG
  • 7. Clinically significant renal impairment that would result in the investigator not normally treating with either study drug
  • 8. Any pre-treatment investigations, the results of which would prompt the investigator not to use either study drug
  • 9. A diagnosis of malignancy or pre-malignant disease where treatments might interfere with ongoing therapy or might cause harm (e.g., history of lymphoma, cervical epithelial neoplasia [CIN], systemic cytotoxic therapy)
  • 10. The patient has a concurrent medical condition that means the investigator would not normally treat the patient with either of the study drugs (for example: a degree of hypertension that would not lead to using either of the study drugs, advanced heart failure, poorly-controlled diabetes, history of peptic ulcer, malignancy in previous years)
  • 11. Administration of a live vaccine (bacillus calmette-guerin [BCG], measles, mumps, rubella, yellow fever, oral polio, oral typhoid) within the last 2 weeks

研究者

发起方
ottingham University Hospitals NHS Trust (UK)

相似试验